NO20044900L - Progestagene doseringsenheter - Google Patents

Progestagene doseringsenheter

Info

Publication number
NO20044900L
NO20044900L NO20044900A NO20044900A NO20044900L NO 20044900 L NO20044900 L NO 20044900L NO 20044900 A NO20044900 A NO 20044900A NO 20044900 A NO20044900 A NO 20044900A NO 20044900 L NO20044900 L NO 20044900L
Authority
NO
Norway
Prior art keywords
progestagen
dosage units
exerts
orally
oral administration
Prior art date
Application number
NO20044900A
Other languages
English (en)
Inventor
Pieter De Haan
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of NO20044900L publication Critical patent/NO20044900L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Foreliggende oppfinnelse angår en metode for å produsere farmasøytiske doseenheter for oral administrering omfattende en progestagen forbindelse som peroralt utøver progestagen aktivitetekvivalent med den til progestagen desogestrel.
NO20044900A 2002-05-29 2004-11-10 Progestagene doseringsenheter NO20044900L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02077097 2002-05-29
PCT/EP2003/050189 WO2003099291A1 (en) 2002-05-29 2003-05-22 Progestagenic dosage units

Publications (1)

Publication Number Publication Date
NO20044900L true NO20044900L (no) 2005-02-25

Family

ID=29558382

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044900A NO20044900L (no) 2002-05-29 2004-11-10 Progestagene doseringsenheter

Country Status (20)

Country Link
US (1) US20050181040A1 (no)
EP (1) EP1511495A1 (no)
JP (1) JP2005529929A (no)
KR (1) KR20050004869A (no)
CN (1) CN1655795A (no)
AR (1) AR040113A1 (no)
AU (1) AU2003238082A1 (no)
BR (1) BR0311209A (no)
CA (1) CA2487279A1 (no)
HR (1) HRP20041102A2 (no)
IL (1) IL165085A0 (no)
IS (1) IS7538A (no)
MX (1) MXPA04011796A (no)
NO (1) NO20044900L (no)
PE (1) PE20040040A1 (no)
PL (1) PL372760A1 (no)
RU (1) RU2004138599A (no)
TW (1) TW200403075A (no)
WO (1) WO2003099291A1 (no)
ZA (1) ZA200409110B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4756153B2 (ja) * 2004-08-27 2011-08-24 富士製薬工業株式会社 低成分含量の錠剤の製造方法
WO2009101182A1 (en) * 2008-02-15 2009-08-20 N.V. Organon Use of etonogestrel for benign prostate hyperplasia (bph).
WO2017000081A1 (zh) * 2015-06-30 2017-01-05 上海交通大学 Etonogestrel在制备抗前列腺癌产品中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2613223B1 (fr) * 1987-04-03 1991-09-13 Biogalenique Laboratoires Forme galenique se presentant sous la forme de grains hydrosolubles, en particulier a base d'un extrait sec de ginkgo biloba, et son procede de preparation
IE71203B1 (en) * 1990-12-13 1997-02-12 Akzo Nv Low estrogen oral contraceptives
IE71202B1 (en) * 1990-12-17 1997-02-12 Akzo Nv Progestagen-only contraceptive
US5395627A (en) * 1992-09-04 1995-03-07 Akzo N.V. Pharmaceutical granulate
IL113816A (en) * 1994-06-08 1998-12-06 Akzo Nobel Nv Pharmaceutical preparations containing desogestral, their preparation and use
US5633011A (en) * 1994-08-04 1997-05-27 Alza Corporation Progesterone replacement therapy
DE69530308T2 (de) * 1994-09-22 2003-10-16 Akzo Nobel Nv Verfahren zur herstellung von dosierungsformen durch feuchtgranulierung
US5595759A (en) * 1994-11-10 1997-01-21 Alza Corporation Process for providing therapeutic composition
US6395300B1 (en) * 1999-05-27 2002-05-28 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
KR100342943B1 (ko) * 1999-08-04 2002-07-02 민경윤 비결정질 세푸록심 악세틸 고형분산체, 이의 제조 방법 및 이를 포함하는 경구투여용 조성물

Also Published As

Publication number Publication date
BR0311209A (pt) 2005-03-15
AR040113A1 (es) 2005-03-16
CA2487279A1 (en) 2003-12-04
TW200403075A (en) 2004-03-01
IL165085A0 (en) 2005-12-18
KR20050004869A (ko) 2005-01-12
AU2003238082A1 (en) 2003-12-12
CN1655795A (zh) 2005-08-17
EP1511495A1 (en) 2005-03-09
JP2005529929A (ja) 2005-10-06
US20050181040A1 (en) 2005-08-18
PE20040040A1 (es) 2004-01-31
ZA200409110B (en) 2005-05-18
IS7538A (is) 2004-11-18
WO2003099291A1 (en) 2003-12-04
PL372760A1 (en) 2005-08-08
MXPA04011796A (es) 2005-03-31
HRP20041102A2 (en) 2004-12-31
RU2004138599A (ru) 2005-06-10

Similar Documents

Publication Publication Date Title
HK1076605A1 (en) Formulations
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
NO20055631L (no) Doseringsform inneholdende pantoprazol som aktiv ingrediens
NO20080827L (no) Faste doseringsformuleringer av narkotiske legemidler som har forbedret bukal adsorpsjon
NO20061818L (no) Fremgangsmate for a inhibere remnant lipoproteinproduksjon
TNSN06012A1 (en) Emulsifying systems containing azetidine derivatives
ECSP045029A (es) Composiciones de valdecoxib de disgregación intraoral
MX2022004197A (es) Inhibidores del factor d del complemento para administracion oral.
DK1359939T3 (da) Sammensætning og fremgangsmåde til potensering af lægemidler
SE0303480D0 (sv) Benzofuranes
TW200503785A (en) Dosage form containing (S)-pantoprazole as active ingredient
PL377683A1 (pl) System terapeutyczny zawierający amoksycylinę i kwas klawulanowy
NO20044900L (no) Progestagene doseringsenheter
RS20050756A (en) Oral pharmaceutical preparation for proton pump antagonists
WO2005051349A3 (en) Pharmaceutical compositions of mirtazapine
ECSP045461A (es) Unidades de dosificación progestagénica
DK1399141T3 (da) Anvendelse af acetyl L-carnitin til fremstilling af et lægemiddel til forebyggende terapi af post-kirurgisk smerte
ECSP055749A (es) Formulacion de tramadol de liberacion sostenida con eficacia de 24 horas
NO20063319L (no) Anvendelse av siramesin i behandlingen av cancer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application